Interferon treatments: how to use an endogenous system as a therapeutic agent.

Abstract

Journal of Interferon ResearchVol. 1992, No. special_issue Interferon Treatments: How to Use an Endogenous System as a Therapeutic AgentF. DIANZANIF. DIANZANISearch for more papers by this authorPublished Online:24 Apr 2009https://doi.org/10.1089/jir.1992.1992.109AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byPlatelet factor 4 promotes rapid replication and propagation of Dengue and Japanese encephalitis virusesEBioMedicine, Vol. 39Complete remission of multiple myeloma after autoimmune hemolytic anemia: Possible association with interferon-α1 January 2007 | American Journal of Hematology, Vol. 82, No. 6DNA Damage Signaling and p53-dependent Senescence after Prolonged β-Interferon StimulationMolecular Biology of the Cell, Vol. 17, No. 4Synthesis and evaluation of 2-substituted 8-hydroxyadenines as potent interferon inducers with improved oral bioavailabilitiesBioorganic & Medicinal Chemistry, Vol. 12, No. 5Prodrugs of 9-Benzyl-8-hydroxy-2-(2-hydroxyethylthio)adenine: Potent Interferon Inducing Agents in MonkeysChemical and Pharmaceutical Bulletin, Vol. 52, No. 4Synthesis and structure–Activity relationships of 2-Amino-8-hydroxyadenines as orally active interferon inducing agentsBioorganic & Medicinal Chemistry, Vol. 11, No. 24Synthesis and structure–activity relationships of 2-substituted-8-hydroxyadenine derivatives as orally available interferon inducers without emetic side effectsBioorganic & Medicinal Chemistry, Vol. 11, No. 17Interferons19 April 2001Russian Experience in Screening, Analysis, and Clinical Application of Novel Interferon Inducers Elina B. Tazulakhova, Olga V. Parshina, Tatiana S. Guseva, and Felix I. Ershov7 July 2004 | Journal of Interferon & Cytokine Research, Vol. 21, No. 2Expression of Interferon-β is Associated with Growth Arrest of Murine and Human Epidermal CellsJournal of Investigative Dermatology, Vol. 112, No. 5Involvement of natural killer cells in endogenous biological retranslationBulletin of Experimental Biology and Medicine, Vol. 126, No. 2Mechanisms of Interferon ActionEffect of Interleukin-12 and Interleukin-10 on the Virus Replication and Apoptosis in T-Cells Infected with Feline Immunodeficiency Virus.Journal of Veterinary Medical Science, Vol. 60, No. 11Interferon antibodies in patients with infectious diseasesBiotherapy, Vol. 10, No. 1A highly sensitive electrochemiluminescence immunoassay for interferon alfa-2b in human serumJournal of Immunological Methods, Vol. 206, No. 1-2Viral Infections: Human Papillomavirus Infections Treated with Immunostimulatory Drugs and Vaccination TherapiesInterferon-betaInterferon antibodies in patients with infectious diseasesLong-acting delivery system of interferon: IFN minipelletJournal of Controlled Release, Vol. 33, No. 2Novel delivery system for proteins using collagen as a carrier material: the minipelletJournal of Controlled Release, Vol. 33, No. 2Immuntherapie der PapillomvirusinfektionenLong-term follow-up of patients with myocarditis and idiopathic dilated cardiomyopathy after immunomodulatory therapyFEMS Immunology & Medical Microbiology, Vol. 10, No. 1Interferon treatment of cutaneous T-cell lymphoma24 April 2009 | European Journal of Haematology, Vol. 51, No. 2 Volume 1992Issue special_issueMay 1992 To cite this article:F. DIANZANI.Interferon Treatments: How to Use an Endogenous System as a Therapeutic Agent.Journal of Interferon Research.May 1992.109-118.http://doi.org/10.1089/jir.1992.1992.109Published in Volume: 1992 Issue special_issue: April 24, 2009PDF download